Skip to content

Clinical trials

Phase 2 Pulmonary Disease, Chronic Obstructive trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Disease, Chronic Obstructive Phase: Phase 2 Country / region: United States Clear all

187 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20012
20034
20046
20055
20066
20078
200820
20099
201015
201111
20129
20135
201410
201510
20163
201710
20188
20195
20203
20214
20224
20235
20246
20256
20267

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed146
Terminated18
Recruiting11
Active, not recruiting6
Withdrawn4
Not yet recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline18
AstraZeneca11
Pearl Therapeutics, Inc.10
Boehringer Ingelheim9
Novartis Pharmaceuticals9
Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA7
Dey6
Chiesi Farmaceutici S.p.A.4
Pfizer4
US Department of Veterans Affairs4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Disease, Chronic Obstructive187
Emphysema26
Bronchitis, Chronic21
Asthma10
Hypertension, Pulmonary7
Lung Diseases6
Dyspnea5
Inflammation4
Pulmonary Emphysema4
alpha 1-Antitrypsin Deficiency4

Trials

Showing 1 to 25 of 187. Each trial links to its page on Pharma Observatory.

87 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.